(Q37467662)

20 August 2017

1 reference

title

Neuroprotective actions of sex steroids in Parkinson's disease (English)

1 reference

20 August 2017

1 reference

3

Thérèse Di Paolo

1 reference

20 August 2017

1

Mélanie Bourque

1 reference

20 August 2017

Dean E Dluzen

2

1 reference

20 August 2017

3 May 2009

1 reference

Frontiers in Neuroendocrinology

20 August 2017

1 reference

20 August 2017

30

1 reference

20 August 2017

2

1 reference

20 August 2017

142-157

1 reference

Major sex differences in non-genomic estrogen actions on intracellular signaling in mouse brain in vivo.

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Anti-oxidative neuroprotection by estrogens in mouse cortical cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The Akt-GSK-3 signaling cascade in the actions of dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Oestrogen as a neuroprotective hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Activation of AKT kinases in cancer: implications for therapeutic targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Virtual and biomolecular screening converge on a selective agonist for GPR30.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Progesterone receptors: form and function in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

17-Beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Multiple pathways transmit neuroprotective effects of gonadal steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Postmenopausal estrogen use affects risk for Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Gender differences in neurological disease: role of estrogens and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Protective effects of estrogen and selective estrogen receptor modulators in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Modulation of brain dopamine transmission by sex steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Methamphetamine-gonadal steroid hormonal interactions: effects upon acute toxicity and striatal dopamine concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen, testosterone, and methamphetamine toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

CREB is a regulatory target for the protein kinase Akt/PKB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

CREB: a major mediator of neuronal neurotrophin responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Oxygen radicals diminish dopamine transporter function in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

New insights into the mechanism of action of amphetamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estradiol upregulates Bcl-2 expression in adult brain neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Hormones and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Protein phosphorylation cascades associated with methamphetamine-induced glial activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Ageing and neurotoxins as causative factors in idiopathic Parkinson's disease--a critical analysis of the neurochemical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Positive association of AKT1 haplotype to Japanese methamphetamine use disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Rapid stimulation of the PI3-kinase/Akt signalling pathway in developing midbrain neurones by oestrogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estradiol prevents the injury-induced decrease of 90 ribosomal S6 kinase (p90RSK) and Bad phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Cloning of a novel receptor expressed in rat prostate and ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Expression of estrogen receptor-alpha and beta mRNA in the developing and adult mouse striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Parkinsonism death rates by race, sex, and geography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

AKT/PKB signaling: navigating downstream

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Risk of Parkinson's disease among first-degree relatives: A community-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Expression and intracellular distribution of the G protein-coupled receptor 30 in rat hippocampal formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

A Population-Based Investigation of Parkinson's Disease With and Without Dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dopamine transporters and neuronal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen and SERM neuroprotection in animal models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Why is parkinsonism not a feature of human methamphetamine users?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Mechanisms of estrogen action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

17beta-estradiol protects cortical neurons against oxidative stress-induced cell death through reduction in the activity of mitogen-activated protein kinase and in the accumulation of intracellular calcium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Steroid receptor interactions with heat shock protein and immunophilin chaperones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Risk of Parkinson disease in women: effect of reproductive characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Rapid estrogen signaling in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

7 January 2021

Estrogens and dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Parkinson's disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Protein kinase B: signalling roles and therapeutic targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Validity of spiral analysis in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The effect of estrogen replacement on early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogens and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen prevents the loss of CA1 hippocampal neurons in gerbils after ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Gender disparities in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen protects primary cortical neurons from glutamate toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Progesterone-induced neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Role of mTOR in physiology and pathology of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen and the brain: beyond ER-alpha and ER-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Non-genomic actions of estrogens and their interaction with genomic actions in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Characterization of the neuroprotective effects of estrogens on hydrogen peroxide-induced cell death in hippocampal HT22 cells: time and dose-dependency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Sexual differences in sensitivity to methamphetamine toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Are men at greater risk for Parkinson's disease than women?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Association between AKT1 gene and Parkinson's disease: a protective haplotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks postpartum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

Effects of female sex steroids on Parkinson's disease in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2009.04.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YFRNE.2009.04.014

1 reference

20 August 2017

1 reference

PubMed ID

19410597